• Clinical Article •
The value of MRI intravoxel incoherent motion imaging (IVIM) and diffusion kurtosis imaging (DKI) in the differential diagnosis of benign and malignant bone and soft tissue tumors of lower extremity
DOI:10.12015/issn.1674-8034.2018.07.008.
| [Abstract] Objective: To evaluate the value of magnetic resonance intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging in the differential diagnosis of benign and malignant bone and soft tissue tumors of lower extremity.Materials and Methods: We collected 54 patients who underwent lower extremity MRI examination found bone or soft tissue masses in the radiology department of our hospital in November 2016 to January 2018.All patients underwent IVIM scan with 14 b values (0, 10, 20, 30, 40, 50, 75, 100, 150, 200, 400, 800, 1000, 1500 s/mm2) and DKI scan with 5 b values (0, 100, 700, 1400, 2100 s/mm2) and routine MRI examination with a 3.0 T MR scanner. IVIM and DKI parameters including ADC, D, D*, f, MK, MD values were measured at a workstation. Patients were divided into benign and malignant bone and soft tissue tumors according to pathological results. Independent two-samples t test was used to evaluate those parameters in differentiating benign and malignant bone and soft tissue tumors. ROC curves were used to evaluate the diagnostic performance of these parameters. Logistic analysis was used to evaluate the diagnostic performance when combinating the parameters of IVIM and DKI.Results: The ADC (1.23±0.27)×10-3 mm2/s), D (1.12±0.22)×10-3 mm2/s, MD (1.26±0.46)×10-3 mm2/s values of malignant bone tumors were statistically lower than that of benign bone tumors (1.95±0.39)×10-3 mm2/s, (1.78±0.42)×10-3 mm2/s, (1.91±0.53)×10-3 mm2/s (P<0.05). The f value of malignant tumors (10.0%±3.98%) was statistically higher than that of benign tumors (3.43%±2.99%) (P<0.05). The MK value [(0.76±0.45)×10-3 mm2/s] was statistically higher than that of benign tumors [(0.36±0.22)×10-3 mm2/s], (P<0.05). There were no significant difference between D* value of benign and malignant tumors (P>0.05). The area under the ROC curves of ADC, D, f, D*, MK, MD were 0.935, 0.939, 0.891, 0.701, 0.840, 0.844. When the optimal threshold of ADC, D, MK and MD was 1.64×10-3 mm2/s, 1.45×10-3 mm2/s, 0.56×10-3 mm2/s, 1.86×10-3 mm2/s, the corresponding diagnostic sensitivity and specificity were 85.7% & 95.2%, 85.7% & 95.2%, 71.4% & 100%, 71.4% & 95.2%. Similiarly, the ADC [(1.27±0.38)×10-3 mm2/s], D [(1.04±0.35)×10-3 mm2/s], MD [(1.53±0.55)×10-3 mm2/s] values of malignant soft tissue tumors were statistically lower than that of benign soft tissue tumors (1.90±0.43)×10-3 mm2/s, (1.71±0.45)×10-3 mm2/s, (2.24±0.60)×10-3 mm2/s (P<0.05). The f value of malignant tumors (8.20%±3.84%) was lower than that of benign tumors (9.62%±4.47%) (P>0.05). The MK value [(0.82±0.56)×10-3 mm2/s] was statistically higher than that of benign tumors [(0.45±0.97)×10-3 mm2/s] (P<0.05). There were no significant difference between D* value of benign and malignant tumors (P>0.05). The area under the ROC curves of ADC, D, f, D*, MK, MD were 0.876, 0.885, 0.633, 0.552, 0.894, 0.812. When the optimal threshold of ADC, D, MK and MD was 1.33×10-3 mm2/s, 1.42×10-3 mm2/s, 0.60×10-3 mm2/s, 1.71×10-3 mm2/s, the corresponding diagnostic sensitivity and specificity were 100% & 60%, 72.7% & 93.3%, 60.0% & 100%, 90.9% & 66.7%.Conclusions: IVIM parameters ADC, D and DKI parameters MK, MD can help to distinguish benign and malignant bone and soft tissue tumors of lower extremity. The combination of parameters of IVIM and DKI can improve the accuracy of the diagnosis of lower extremity tumors. |
| [Keywords] Bone neoplasms；Soft tissue neoplasms；Magnetic resonance imaging |
ZHANG Xiao-li Department of Radiology, Tongji Hospital of Tongji Medical College of HuaZhong University of Science and Technology, Wuhan 430030, China
WU Gang Department of Radiology, Tongji Hospital of Tongji Medical College of HuaZhong University of Science and Technology, Wuhan 430030, China
XIE Ru-yi Department of Radiology, Tongji Hospital of Tongji Medical College of HuaZhong University of Science and Technology, Wuhan 430030, China
LIANG Xiao-qing Department of Radiology, Tongji Hospital of Tongji Medical College of HuaZhong University of Science and Technology, Wuhan 430030, China
LIU Xuan-lin Department of Radiology, Tongji Hospital of Tongji Medical College of HuaZhong University of Science and Technology, Wuhan 430030, China
LI Xiao-ming* Department of Radiology, Tongji Hospital of Tongji Medical College of HuaZhong University of Science and Technology, Wuhan 430030, China
*Correspondence to: Li XM, E-mail: lilyboston2002@163.com
Conflicts of interest None.
| ACKNOWLEDGMENTS The project is funded by the National Natural Science Foundation of China No. 81571643 |
| Received 2017-12-20 |
| Accepted 2018-06-20 |
| DOI: 10.12015/issn.1674-8034.2018.07.008 |
| DOI:10.12015/issn.1674-8034.2018.07.008. |
[1]
Teixeira PA, Beaumont M, Gabriela H, et al. Advanced techniques in musculoskeletal oncology: perfusion, diffusion, and spectroscopy. Semin Musculoskelet Radiol, 2015, 19(5): 463-674.
[2]
Surov A, Nagata S, Razek AA, et al. Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis. Skeletal Radiol, 2015, 44(7): 995-1000.
[3]
Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology, 1988, 168(2): 497-505.
[4]
Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magnetic resonance Med, 2005, 53(6): 1432-1440.
[5]
Pesapane F, Patella F, Fumarola EM, et al. Intravoxel incoherent motion (IVIM) diffusion weighted imaging (DWI) in the periferic prostate cancer detection and stratification. Med Oncol, 2017, 34(3): 35.
[6]
Park S, Kwack KS, Chung NS, et al. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging of focal vertebral bone marrow lesions: initial experience of the differentiation of nodular hyperplastic hematopoietic bone marrow from malignant lesions. Skeletal Radiol, 2017, 46(5): 675-683.
[7]
Iima M, Nobashi T, Imai H, et al. Effects of diffusion time on non-Gaussian diffusion and intravoxel incoherent motion (IVIM) MRI parameters in breast cancer and hepatocellular carcinoma xenograft models. Acta radiologica open, 2018, 7(1): 1-8.
[8]
Iima M, Kataoka M, Kanao S, et al. Variability of non-Gaussian diffusion MRI and intravoxel incoherent motion (IVIM) measurements in the breast. PLoS One, 2018, 13(3): e0193444.
[9]
Zhang YD, Wu CJ, Bao ML, et al. New RESOLVE-based diffusional kurtosis imaging in MRI-visible prostate cancer: effect of reduced b value on image quality and diagnostic effectiveness. AJR Am J Roentgenol, 2016, 207(2): 330-338.
[10]
Sun K, Chen X, Chai W, et al. Breast cancer: diffusion kurtosis MR imaging-diagnostic accuracy and correlation with clinical-pathologic factors. Radiology, 2015, 277(1): 46-55.
[11]
Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology, 2014, 46(2): 95-104.
[12]
Ginat DT, Mangla R, Yeaney G, et al. Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. AJR Am J Roentgenol, 2012, 198(6): W597-601.
[13]
Liu C, Wang K, Chan Q, et al. Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging. Eur Radiol, 2016, 26(11): 3888-3898.
[14]
Nogueira L, Brandao S, Matos E, et al. Application of the diffusion kurtosis model for the study of breast lesions. Eur Radiol, 2014, 24(6): 1197-1203.
[15]
Muller U, Kubik-Huch RA, Ares C, et al. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma? Acta Radiol, 2016, 57(2): 225-232.
[16]
Oh E, Yoon YC, Kim JH, et al. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults. Clin Radiol, 2017, 72(7): 552-559.
[17]
Douis H, Davies MA, Sian P. The role of diffusion-weighted MRI (DWI) in the differentiation of benign from malignant skeletal lesions of the pelvis. Eur J Radiol, 2016, 85(12): 2262-2268.
[18]
Ahlawat S, Khandheria P, Subhawong TK, et al. Differentiation of benign and malignant skeletal lesions with quantitative diffusion weighted MRI at 3T. Eur J Radiol, 2015, 84(6): 1091-1097.
[19]
Cao J, Xiao L, He B, et al. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions. Clin Radiol, 2017, 72(9): 793, e1-793, e9.
[20]
Lim HK, Jee WH, Jung JY, et al. Intravoxel incoherent motion diffusion-weighted MR imaging for differentiation of benign and malignant musculoskeletal tumours at 3 T. Br J Radiol, 2018, 91(1082): 20170636.
[21]
Yakushiji T, Oka K, Sato H, et al. Characterization of chondroblastic osteosarcoma: gadolinium-enhanced versus diffusion-weighted MR imaging. J Magn Reson Imaging, 2009, 29(4): 895-900.
[22]
Balliu E, Vilanova JC, Pelaez I, et al. Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions. Eur J Radiol, 2009, 69(3): 560-566.
[23]
Neubauer H, Evangelista L, Hassold N, et al. Diffusion-weighted MRI for detection and differentiation of musculoskeletal tumorous and tumor-like lesions in pediatric patients. World J Pediatr, 2012, 8(4): 342-349.
[24]
Messiou C, Collins DJ, Morgan VA, et al. Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol, 2011, 21(8): 1713-1718.
[25]
Yoon JH, Lee JM, Baek JH, et al. Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr, 2014, 38(1): 110-116.
[26]
Dia AA, Hori M, Onishi H, et al. Application of non-Gaussian water diffusional kurtosis imaging in the assessment of uterine tumors: a preliminary study. PLoS One, 2017, 12(11): e0188434.
[27]
van Rijswijk CS, Kunz P, Hogendoorn PC, et al. Diffusion-weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging, 2002, 15(3): 302-307.
[28]
Costa FM, Ferreira EC, Vianna EM. Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors. Magn Reson Imaging Clin N Am, 2011, 19(1): 159-180.
[29]
Nagata S, Nishimura H, Uchida M, et al. Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med, 2008, 26(5): 287-295.
[30]
Einarsdottir H, Karlsson M, Wejde J, et al. MRI of soft tissue tumours. Eur Radiol, 2004, 14(6): 959-963.
[31]
Maeda M, Matsumine A, Kato H, et al. Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: influence of myxoid matrix on the apparent diffusion coefficient. J Magn Reson Imaging, 2007, 25(6): 1199-1204.
[32]
Wang LL, Lin J, Liu K, et al. Intravoxel incoherent motion diffusion-weighted MR imaging in differentiation of lung cancer from obstructive lung consolidation: comparison and correlation with pharmacokinetic analysis from dynamic contrast-enhanced MR imaging. Eur Radiol, 2014, 24(8): 1914-1922.
[33]
Sumi M, Van Cauteren M, Sumi T, et al. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology, 2012, 263(3): 770-777.
